1. Risk Factors, Mechanisms and Treatments of Thromboangiitis Obliterans: An Overview of Recent Research
   Meng-di Li et al, 2020, Current Medicinal Chemistry CrossRef
2. Case report: morphological aspects of Buerger's disease
   N.S. Tsimbalist et al, 2020, Bulletin of Russian State Medical University CrossRef
3. Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways
   Chongchong Zou et al, 2022, Frontiers in Pharmacology CrossRef